Management of a Pediatric Patient With Langerhans Cell Histiocytosis Using General Anesthesia
Bashaer S Abdulhadi1, Meshari S Alzahrani1
1Pediatric Dentistry, King Fahad Armed Forces Hospital, Jeddah, SAU.
Insights
Langerhans cell histiocytosis (LCH) management requires multidisciplinary care, especially for multisystem cases. This case highlights successful dental rehabilitation during chemotherapy for a child with LCH.
Area of Science:
- Pediatric Oncology
- Hematology
- Dentistry
Background:
- Langerhans cell histiocytosis (LCH) is a rare clonal proliferative disease.
- Multisystem LCH often requires a multidisciplinary approach for optimal patient outcomes.
- Dental involvement in LCH can be extensive and impact treatment planning.
Abstract:
Langerhans cell histiocytosis (LCH) is an uncommon condition that often calls for input from several specialists, especially when the mouth is involved or when treatment affects the child's immune system. This report outlines the care of a five-year-old female with multisystem disease who developed fever and eye irritation during chemotherapy. Once her blood counts recovered, she received full dental rehabilitation under general anesthesia because of extensive decay and limited cooperation. Close coordination among oncology, dental, pediatric, and eye-care teams supported her recovery and highlighted the value of timely intervention and organized long-term follow-up.
